Psychiatry & Neurology Doctors in Las Vegas, NM Accepting Medicare

7 Psychiatry & Neurology doctors found. Showing 1 - 7

Dr. Teresa Ann O'brien, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 3695 Hot Springs Blvd, Las Vegas, NM 87701 Phone: 505-454-2100

Catherine Boyd, Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 3695 Hot Springs Blvd, Las Vegas, NM 87701 Phone: 505-454-2100

Luigi Dulanto, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 3695 Hot Springs Blvd, Las Vegas, NM 87701 Phone: 505-454-2100

Michael Gzaskow, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 700 Friedman Ave, Las Vegas, NM 87701 Phone: 505-454-5100

Dr. Jerry K Williams Jr., M.D. Psychiatry & Neurology - Neurology with Special Qualifications in Child Neurology Medicare: Not Enrolled in Medicare Practice Location: 2301 7th St, Suite B, Las Vegas, NM 87701 Phone: 505-426-1200    Fax: 505-426-1202

Pierre-yves Rouzaud, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 3695 Hot Springs Blvd, Las Vegas, NM 87701 Phone: 505-454-2100

Brenda White, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 700 Friedman Ave, Las Vegas, NM 87701 Phone: 505-454-5100

News Archive

Special issue on Helicobacter pylori provides new insights into diagnosis, prevention and treatment

A special issue on Helicobacter pylori has been published by Landes Bioscience (Austin, TX USA). The articles contained in this special issue of the journal Gut Microbes have been authored by world-class investigators and provide new insights into the pathophysiology, diagnosis, prevention, and treatment of this microbe.

Study finds a sharp decline in heart transplants during the pandemic

The number of heart transplants in the United States declined sharply during the beginning of the pandemic, even in areas of the country with few COVID-19 cases at the time, according to an analysis by researchers at Columbia University Irving Medical Center.

Cutting U.S. global health funding would slow progress, hurt development in other countries

A Minnesota Daily editorial states that a proposed nine percent cut in U.S. global health program funding "would drastically slow ... progress and hurt development and advancement in other countries," adding that "investing in the development of poor countries is good for everyone involved. When there are more highly educated, healthy countries, there is more prosperity for all."

Novel peptide NX002 demonstrates efficacy in animal model of oral mucositis: Study

NephRx Corporation today announced that a new study has shown that its novel peptide NX002 demonstrated significant efficacy when tested in an animal model of oral mucositis. Mucositis is a debilitating and often dose-limiting side effect of many forms of cancer therapy that affects more than 400,000 patients who receive chemotherapy or radiation treatment in the U.S. each year. Current treatment options are very limited.

CSL Behring announces results of rIX-FP Phase I study on hemophilia B

CSL Behring today announced the results of a Phase I study evaluating recombinant fusion protein linking coagulation Factor IX with albumin (rIX-FP) in patients with severe hemophilia B.

Read more Medical News

› Verified 8 days ago